Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis. Issue 8 (15th July 2009) - Grabar, P Bohanec; Rozman, B; Logar, D; Praprotnik, S; Dolžan, V